Franklin Resources Inc Adaptive Biotechnologies Corp Transaction History

Franklin Resources Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.34 - $3.96 $62,070 - $105,042	26,526 Added 26.15%	127,975 $463,000
Q1 2024 May 13, 2024	BUY	$2.88 - $4.8 $248,788 - $414,648	86,385 Added 573.45%	101,449 $325,000
Q4 2023 Feb 09, 2024	SELL	$3.46 - $5.33 $1,840 - $2,835	-532 Reduced 3.41%	15,064 $73,000
Q3 2023 Nov 13, 2023	SELL	$5.07 - $8.44 $100,872 - $167,922	-19,896 Reduced 56.06%	15,596 $84,000
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $101,454 - $143,904	16,390 Added 85.8%	35,492 $238,000
Q1 2023 May 12, 2023	SELL	$7.8 - $10.11 $249 - $323	-32 Reduced 0.17%	19,102 $168,000
Q4 2022 Feb 10, 2023	BUY	$6.26 - $9.34 $2,716 - $4,053	434 Added 2.32%	19,134 $146,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $121,550 - $236,929	18,700 New	18,700 $133,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.